EUCTR2015-001919-13-RO进行中（未招募）1 期
Pharmacogenetic testing of saliva samples from patients with =5 exposure days to rFVIIa analogue in the adept™2 trial.Bio-specimen research study
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •1. Informed consent obtained before collection of saliva samples
- •2. Previous participation in adept™2 trial with =5 exposure days to rFVIIa analogue
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 1
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 27
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 0
排除标准
- •No exclusion criteria apply
研究者
相似试验
已完成
2 期
Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 TrialCongenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With InhibitorsNCT02541942Novo Nordisk A/S19
进行中（未招募）
不适用
se of saliva for screening patients with COVID-19Coronavirus Infections37050RBR-5sw6sjzInstituto Federal do Paraná
尚未招募
不适用
To check for neonatal infections using salivaCTRI/2017/04/008427Spot Healthcare Solutions Pvt Ltd100
已完成
Unknown
Application of saliva markers for the in vivo testing of dosage formsDetermination of the gastric residence time of a new formulation compared to an established formulationDRKS00031999Institut für Pharmazie - Biopharmazie & Pharmazeutische Technologie12
尚未招募
不适用
Testing Saliva for SARS-CoV-2CTRI/2020/09/027597Asian Healthcare Foundation